Detalhe da pesquisa
1.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood;
143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38194692
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet;
403(10441): 2293-2306, 2024 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38705160
3.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Blood;
142(10): 878-886, 2023 09 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37319435
4.
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.
Blood;
142(2): 141-145, 2023 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37130017
5.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood;
142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37300386
6.
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.
Oncologist;
2024 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38339976
7.
The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma.
Blood;
140(4): 303-308, 2022 07 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35580172
8.
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study.
Haematologica;
109(4): 1184-1193, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37646659
9.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging;
51(5): 1361-1370, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38114616
10.
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel.
Hematol Oncol;
42(2): e3255, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38362952
11.
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Hematol Oncol;
42(1): e3215, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37649350
12.
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study.
Ann Hematol;
103(3): 803-811, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37950052
13.
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.
Ann Hematol;
2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38695872
14.
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Neurol Sci;
2024 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38512531
15.
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report.
Chemotherapy;
69(1): 23-26, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37913761
16.
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Clin Infect Dis;
76(3): e426-e438, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35607769
17.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol;
202(4): 749-759, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36257914
18.
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Mod Pathol;
36(12): 100323, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37678673
19.
Peripheral T-cell lymphomas.
Hematol Oncol;
41 Suppl 1: 82-87, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37294962
20.
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel.
Hematol Oncol;
41(5): 795-808, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37165730